$PLUR
Pluri Inc. Stock $plur

$plur Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000121390024079861 Filed on September 18, 2024

Income Statement

Concept	2024 Q3	2024 Q2	2024
Revenue	$326.0K	$96.00K	$326.0K
YoY Change	503.7%	-12.73%	13.59%
Cost Of Revenue	$126.0K	$4.000K	$4.000K
YoY Change		-60.0%	-55.56%
Gross Profit	$200.0K	$92.00K	$322.0K
YoY Change	270.37%	-8.0%	15.83%
Gross Profit Margin	61.35%	95.83%	98.77%
Selling, General & Admin	$2.509M	$2.731M	$10.03M
YoY Change	2.83%	-12.47%	-14.82%
% of Gross Profit	1254.5%	2968.48%	3116.15%
Research & Development	$2.889M	$3.714M	$12.45M
YoY Change	-14.17%	-7.15%	-28.52%
% of Gross Profit	1444.5%	4036.96%	3865.22%
Depreciation & Amortization	$65.00K	$61.00K	$253.0K
YoY Change	-2.99%	-12.86%	-30.11%
% of Gross Profit	32.5%	66.3%	78.57%
Operating Expenses	$2.889M	$5.736M	$12.45M
YoY Change	-14.17%	-13.74%	-28.52%
Operating Profit	-$5.198M	-$5.644M	-$22.16M
YoY Change	-3.33%	-13.83%	-18.67%
Interest Expense	-$217.0K	-$218.0K	$722.0K
YoY Change	-201.4%	263.33%	-14.35%
% of Operating Profit
Other Income/Expense, Net	-$838.0K	$390.0K	$814.0K
YoY Change	-400.36%		-149.6%
Pretax Income	-$6.036M	-$5.862M	-$21.34M
YoY Change	18.35%	-11.32%	-26.12%
Income Tax
% Of Pretax Income
Net Earnings	-$5.882M	-$5.729M	-$20.89M
YoY Change	18.56%	-13.33%	-26.25%
Net Earnings / Revenue	-1804.29%	-5967.71%	-6407.36%
Basic Earnings Per Share	-$1.08		-$3.99
Diluted Earnings Per Share	-$1.08	-$1.07	-$3.99
COMMON SHARES
Basic Shares Outstanding	5.470M shares	5.389M shares	5.240M shares
Diluted Shares Outstanding	5.459M shares		5.240M shares

Balance Sheet

Concept	2024 Q3	2024 Q2	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$25.66M	$29.99M	$29.99M
YoY Change	-23.66%	-25.35%	-25.35%
Cash & Equivalents	$3.198M	$6.783M	$6.783M
Short-Term Investments	$22.46M	$23.20M	$23.20M
Other Short-Term Assets	$1.373M	$1.122M	$476.0K
YoY Change	-16.79%	-0.71%	-32.96%
Inventory
Prepaid Expenses		$222.0K
Receivables			$467.0K
Other Receivables			$179.0K
Total Short-Term Assets	$27.03M	$31.11M	$31.11M
YoY Change	-23.33%	-24.88%	-24.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$846.0K	$688.0K	$7.246M
YoY Change	10.16%	0.0%	-12.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$20.00K	$70.00K	$1.174M
YoY Change	185.71%	6900.0%	9.72%
Total Long-Term Assets	$8.410M	$8.420M	$8.420M
YoY Change	-9.41%	-10.31%	-10.33%
TOTAL ASSETS
Total Short-Term Assets	$27.03M	$31.11M	$31.11M
Total Long-Term Assets	$8.410M	$8.420M	$8.420M
Total Assets	$35.44M	$39.53M	$39.53M
YoY Change	-20.43%	-22.19%	-22.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.129M	$964.0K	$964.0K
YoY Change	16.39%	-46.74%	-46.74%
Accrued Expenses	$1.103M	$1.223M	$3.366M
YoY Change	7.71%	1.16%	-8.28%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.583M	$4.454M	$4.454M
YoY Change	6.04%	-20.76%	-20.75%
LONG-TERM LIABILITIES
Long-Term Debt	$25.37M	$24.03M	$24.03M
YoY Change	9.47%	2.11%	2.11%
Other Long-Term Liabilities	$5.557M	$5.631M	$5.631M
YoY Change	-7.54%	-11.32%	-11.32%
Total Long-Term Liabilities	$30.92M	$29.66M	$29.66M
YoY Change	5.96%	-0.73%	-0.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.583M	$4.454M	$4.454M
Total Long-Term Liabilities	$30.92M	$29.66M	$29.66M
Total Liabilities	$35.51M	$34.11M	$39.43M
YoY Change	5.97%	-3.9%	5.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$426.4M	-$420.5M
YoY Change	5.39%	5.23%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.283M	$96.00K	$96.00K
YoY Change
Total Liabilities & Shareholders Equity	$35.44M	$39.53M	$39.53M
YoY Change	-20.43%	-22.19%	-22.19%

Cashflow Statement

Concept	2024 Q3	2024 Q2	2024
OPERATING ACTIVITIES
Net Income	-$5.882M	-$5.729M	-$20.89M
YoY Change	18.56%	-13.33%	-26.25%
Depreciation, Depletion And Amortization	$65.00K	$61.00K	$253.0K
YoY Change	-2.99%	-12.86%	-30.11%
Cash From Operating Activities	-$4.064M	-$4.313M	-$18.02M
YoY Change	-30.61%	48.72%	-21.16%
INVESTING ACTIVITIES
Capital Expenditures	$208.0K	$10.00K	$323.0K
YoY Change	101.94%	-88.89%	23.28%
Acquisitions
YoY Change
Other Investing Activities	$793.0K	-$4.795M	$10.91M
YoY Change	-86.58%	-208.48%	9.51%
Cash From Investing Activities	$585.0K	-$4.805M	$10.58M
YoY Change	-89.92%	-210.97%	9.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$91.00K
YoY Change			-98.87%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		8.841M	$8.841M
YoY Change		-88510.0%	10.18%
NET CHANGE
Cash From Operating Activities	-$4.064M	-4.313M	-$18.02M
Cash From Investing Activities	$585.0K	-4.805M	$10.58M
Cash From Financing Activities		8.841M	$8.841M
Net Change In Cash	-$3.455M	-277.0K	$1.415M
YoY Change	3461.86%	-119.51%	-127.44%
FREE CASH FLOW
Cash From Operating Activities	-$4.064M	-$4.313M	-$18.02M
Capital Expenditures	$208.0K	$10.00K	$323.0K
Free Cash Flow	-$4.272M	-$4.323M	-$18.34M
YoY Change	-28.32%	44.58%	-20.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue		usd
CY2024	dei	Local Phone Number LocalPhoneNumber	74-7108600
CY2024	dei	City Area Code CityAreaCode	011-972
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.99
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.24
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5240249	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4581503	shares
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-31392
CY2024	dei	Entity Registrant Name EntityRegistrantName	PLURI INC.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0351734
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	MATAM Advanced Technology Park
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	Building No. 5
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Haifa
CY2024	dei	Entity Address Country EntityAddressCountry	IL
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	3508409
CY2024	dei	Security12b Title Security12bTitle	Common Shares, par value $0.00001
CY2024	dei	Trading Symbol TradingSymbol	PLUR
CY2024	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	22856362	usd
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5470163	shares
CY2024	dei	Auditor Firm AuditorFirmId	1309
CY2024	dei	Auditor Name AuditorName	Kesselman & Kesselman
CY2024	dei	Auditor Location AuditorLocation	Haifa, Israel
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6783000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5360000	usd
CY2024Q2	plur	Shortterm Bank Deposits ShorttermBankDeposits	23202000	usd
CY2023Q2	plur	Shortterm Bank Deposits ShorttermBankDeposits	34811000	usd
CY2024Q2	us-gaap	Restricted Cash RestrictedCash	254000	usd
CY2023Q2	us-gaap	Restricted Cash RestrictedCash	269000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	868000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	969000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	31107000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	41409000	usd
CY2024Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	634000	usd
CY2023Q2	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	627000	usd
CY2024Q2	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	470000	usd
CY2023Q2	us-gaap	Defined Benefit Plan Assets For Plan Benefits Noncurrent DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent	439000	usd
CY2024	plur	Property Plant And Equipments Useful Life PropertyPlantAndEquipmentsUsefulLife	The shorter of the expected useful life or the term of the lease.
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	688000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	688000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6558000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7633000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	70000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1000	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	8420000	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	9388000	usd
CY2024Q2	us-gaap	Assets Assets	39527000	usd
CY2023Q2	us-gaap	Assets Assets	50797000	usd
CY2024Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	964000	usd
CY2023Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1812000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1223000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1209000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	559000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	627000	usd
CY2024Q2	plur	Accrued Vacations Current AccruedVacationsCurrent	702000	usd
CY2023Q2	plur	Accrued Vacations Current AccruedVacationsCurrent	873000	usd
CY2024Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1006000	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1100000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4454000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5621000	usd
CY2024Q2	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	605000	usd
CY2023Q2	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	598000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5026000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5748000	usd
CY2024Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	24027000	usd
CY2023Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	23530000	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	29658000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	29876000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	420568000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	412939000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-420472000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399584000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	96000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13355000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	5319000	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	1945000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5415000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15300000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	39527000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50797000	usd
CY2024	us-gaap	Revenues Revenues	326000	usd
CY2023	us-gaap	Revenues Revenues	287000	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	4000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	9000	usd
CY2024	us-gaap	Gross Profit GrossProfit	322000	usd
CY2023	us-gaap	Gross Profit GrossProfit	278000	usd
CY2024	plur	Research And Development Expenses ResearchAndDevelopmentExpenses	13780000	usd
CY2023	plur	Research And Development Expenses ResearchAndDevelopmentExpenses	17413000	usd
CY2024	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	1334000	usd
CY2023	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	1668000	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12446000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15745000	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10034000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11779000	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-22158000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-27246000	usd
CY2024	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1680000	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-798000	usd
CY2024	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	866000	usd
CY2023	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	843000	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	814000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1641000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-21344000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-28887000	usd
CY2024	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-456000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-566000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-20888000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-28321000	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.99
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.24
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5240249	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4581503	shares
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	32186000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3977000	usd
CY2023	plur	Net Of Issuance Costs NetOfIssuanceCosts	445000	usd
CY2023	plur	Issuance Of Common Stock And Warrants IssuanceOfCommonStockAndWarrants	8024000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-28887000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15300000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15300000	usd
CY2024	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2618000	usd
CY2024	plur	Sales Agreement Of Net Issuance Costs SalesAgreementOfNetIssuanceCosts	162000	usd
CY2024	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	91000	usd
CY2024	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	8750000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-21344000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5415000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-21344000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-28887000	usd
CY2024	us-gaap	Depreciation Depreciation	253000	usd
CY2023	us-gaap	Depreciation Depreciation	362000	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	2618000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3977000	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-32000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-768000	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-778000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-22000	usd
CY2024	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-251000	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1243000	usd
CY2024	plur	Increasedecrease In Operating Lease Rightofuse Asset And Liability Net IncreasedecreaseInOperatingLeaseRightofuseAssetAndLiabilityNet	-285000	usd
CY2023	plur	Increasedecrease In Operating Lease Rightofuse Asset And Liability Net IncreasedecreaseInOperatingLeaseRightofuseAssetAndLiabilityNet	112000	usd
CY2024	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-438000	usd
CY2023	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	336000	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	253000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	831000	usd
CY2024	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	497000	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1852000	usd
CY2024	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-24000	usd
CY2023	us-gaap	Increase Decrease In Pension And Postretirement Obligations IncreaseDecreaseInPensionAndPostretirementObligations	-47000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18021000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22857000	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	323000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	262000	usd
CY2024	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-10907000	usd
CY2023	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-9960000	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	10584000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9698000	usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	91000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8024000	usd
CY2024	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	8750000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8841000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8024000	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-22000	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1415000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5157000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6256000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11413000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7671000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6256000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6783000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5360000	usd
CY2024Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	254000	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	269000	usd
CY2024Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	634000	usd
CY2023Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	627000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7671000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6256000	usd
CY2024	plur	Purchase Of Propertys And Equipment On Credit PurchaseOfPropertysAndEquipmentOnCredit	4000	usd
CY2023	plur	Purchase Of Propertys And Equipment On Credit PurchaseOfPropertysAndEquipmentOnCredit	74000	usd
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	82000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	60000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-420472000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	96000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-21344000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18021000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	30873000	usd
	plur	Reverse Stock Split Arrangement ReverseStockSplitArrangement	1-for-8
CY2024	plur	Stock Issued During Period Shares Reverse Stock Split StockIssuedDuringPeriodSharesReverseStockSplit	67836	shares
CY2022Q1	plur	Investment In Even After Subsidiary InvestmentInEvenAfterSubsidiary	7500000	usd
CY2022Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	187500	shares
CY2022Q1	plur	Additional Investment AdditionalInvestment	7500000	usd
CY2024	plur	Allocated Consideration AllocatedConsideration	7500000	usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0108	pure
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.85	pure
CY2024	plur	Compensation Expense Recognized During The Period CompensationExpenseRecognizedDuringThePeriod	385000	usd
CY2024Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10000000	usd
CY2024Q2	plur	Subsidiary Investment SubsidiaryInvestment	1250000	usd
CY2024	plur	Capital Consideration CapitalConsideration	8750000	usd
CY2024	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	3185000	usd
CY2024	plur	Percentage Of Company Held In Subsidiary By Limited Liability Or Partnership PercentageOfCompanyHeldInSubsidiaryByLimitedLiabilityOrPartnership	0.69	pure
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments, and assumptions that are reasonable based upon information available at the time they are made. Estimates are primarily used for, but not limited to, valuation of share-based compensation, valuation of warrants and determining the valuation and terms of leases. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes, and actual results could differ from those estimates.</p>
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	3.85
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	3.65
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.7844	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2024	plur	Aggregate Amount AggregateAmount	1113000	usd
CY2023	plur	Aggregate Amount AggregateAmount	2426000	usd
CY2024	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	1334000	usd
CY2023	plur	Government And Third Party Grants Received GovernmentAndThirdPartyGrantsReceived	1668000	usd
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1635190	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1768948	shares
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>o.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of credit risk</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash, short-term bank deposits, long-term restricted bank deposits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The majority of the Company’s cash and cash equivalents, restricted cash, short-term bank deposits and long-term restricted deposits are mainly invested in the New Israeli Shekel, or NIS, and U.S. dollar deposits of major banks in Israel and in the United States. Deposits in the United States may be in excess of insured limits and are not insured in other jurisdictions. Generally, these deposits may be redeemed upon demand and therefore bear minimal risk. The Company invests its surplus cash in cash deposits in financial institutions and has established guidelines, approved by the Company’s Investment Committee, relating to diversification and maturities to maintain safety and liquidity of the investments.</p>
CY2024	us-gaap	Severance Costs1 SeveranceCosts1	632000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	732000	usd
CY2024Q2	plur	Accrued Royalties Amount AccruedRoyaltiesAmount	3000	usd
CY2024	plur	Financial Income Expense FinancialIncomeExpense	148000	usd
CY2023	plur	Financial Income Expense FinancialIncomeExpense	-157000	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	222000	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	442000	usd
CY2024Q2	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	135000	usd
CY2023Q2	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	129000	usd
CY2024Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	34000	usd
CY2023Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	110000	usd
CY2024Q2	us-gaap	Other Receivables OtherReceivables	10000	usd
CY2023Q2	us-gaap	Other Receivables OtherReceivables	38000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	868000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	969000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18388000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18135000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17700000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17447000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	688000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	688000	usd
CY2024	us-gaap	Depreciation Depreciation	253000	usd
CY2023	us-gaap	Depreciation Depreciation	362000	usd
CY2024Q2	plur	Grants Received In Advance GrantsReceivedInAdvance	81000	usd
CY2023Q2	plur	Grants Received In Advance GrantsReceivedInAdvance	144000	usd
CY2024Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	467000	usd
CY2023Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	501000	usd
CY2024Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	43000	usd
CY2023Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	7000	usd
CY2024Q2	plur	Other Accounts Payable Payroll Institutions OtherAccountsPayablePayrollInstitutions	415000	usd
CY2023Q2	plur	Other Accounts Payable Payroll Institutions OtherAccountsPayablePayrollInstitutions	448000	usd
CY2024Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1006000	usd
CY2023Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1100000	usd
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	292000	ils
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	78000	usd
CY2024	plur	Lease Payments Increase Percentage LeasePaymentsIncreasePercentage	0.10	pure
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6558000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7633000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	559000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	627000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5026000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5748000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	5585000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	6375000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1113000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1011000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	977000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1023000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	3583000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7707000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2122000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	5585000	usd
CY2024	us-gaap	Variable Lease Cost VariableLeaseCost	1250000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	1304000	usd
CY2024	us-gaap	Sublease Income SubleaseIncome	50000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	36000	usd
CY2024	plur	Cash Paid For Amounts Included In The Measurement Of Lease Liabilities CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilities	1178000	usd
CY2023	plur	Cash Paid For Amounts Included In The Measurement Of Lease Liabilities CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilities	1196000	usd
CY2024Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P7Y4M24D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.09	pure
CY2023Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P8Y1M6D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.09	pure
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2020Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	50000000	eur
CY2020Q2	plur	Finance Contract Period FinanceContractPeriod	P36Y
CY2024Q2	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent	3000	usd
CY2021Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	20000000	eur
CY2021Q2	plur	Due Date DueDate	2026-06-01
CY2024Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	21390000	usd
CY2024Q2	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	2637000	usd
CY2024Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	888000	usd
CY2024	plur	Percentage Of Qualified Expenditures PercentageOfQualifiedExpenditures	0.50	pure
CY2024	plur	Royalty Rate Sales RoyaltyRateSales	0.03	pure
CY2024	plur	Royalty Rate Payable On Grants Received RoyaltyRatePayableOnGrantsReceived	1	pure
CY2024Q2	plur	Contingent Liability In Respect To Royalties ContingentLiabilityInRespectToRoyalties	27565000	usd
CY2017Q3	plur	Marketing And Business Development Activities MarketingAndBusinessDevelopmentActivities	229000	usd
CY2017Q3	plur	Royalties Revenues Percentage RoyaltiesRevenuesPercentage	0.05	pure
CY2017Q3	plur	Spread Period SpreadPeriod	P5Y
CY2023Q2	us-gaap	Royalty Guarantees Commitments Amount RoyaltyGuaranteesCommitmentsAmount	180000	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	37500000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1019488	shares
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1019488	shares
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.24
CY2022Q4	us-gaap	Common Unit Issued CommonUnitIssued	697485	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	697485	shares
CY2022Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	8.24
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.4
CY2022Q4	us-gaap	Common Unit Issued CommonUnitIssued	258565	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	258565	shares
CY2022Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	8.4
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.48
CY2022Q4	us-gaap	Common Unit Issued CommonUnitIssued	29688	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	29688	shares
CY2022Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	8.48
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.72
CY2022Q4	us-gaap	Common Unit Issued CommonUnitIssued	16875	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	16875	shares
CY2022Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	8.72
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.96
CY2022Q4	us-gaap	Common Unit Issued CommonUnitIssued	16875	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	16875	shares
CY2022Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	8.96
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	445000	usd
CY2024Q1	plur	Aggregate Gross Proceeds AggregateGrossProceeds	10000	usd
CY2024Q2	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	5.93
CY2023Q3	plur	Aggregate Amount Received AggregateAmountReceived	2500000	usd
CY2024Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	642650	shares
CY2024	plur	Annual Cash Salary AnnualCashSalary	375000000	usd
CY2024Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y
CY2024Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	8.96
CY2024	plur	Ce Os Grant Agreements Description CEOsGrantAgreementsDescription	In addition, the Board also agreed to grant Mr. Yanay options to purchase 187,500 common shares, with a term of 3 years, with the following terms: (i) options to purchase 62,500 common shares at an exercise price of $12.48 per share, 50% vesting on June 30, 2023 and 50% vesting on December 31, 2023, (ii) options to purchase 62,500 common shares at an exercise price of $16.64 per share, 50% vesting on June 30, 2023 and 50% vesting on December 31, 2023, and (iii) options to purchase 62,500 common shares at an exercise price of $20.80 per share, 50% vesting on June 30, 2023 and 50% vesting on December 31, 2023.
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	170000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	205000	usd
CY2024Q2	plur	Share Based Compensation Share Authorized Under Stock Warrants Plans Exercise Price Range Number Of Outstanding Warrants ShareBasedCompensationShareAuthorizedUnderStockWarrantsPlansExercisePriceRangeNumberOfOutstandingWarrants	1019488	shares
CY2024Q2	plur	Share Based Compensation Shares Authorized Under Stock Of Warrants Plans Exercise Price Range Number Of Exercisable Warrants ShareBasedCompensationSharesAuthorizedUnderStockOfWarrantsPlansExercisePriceRangeNumberOfExercisableWarrants	1019488	shares
CY2024Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	257766	shares
CY2024Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	248391	shares
CY2024Q2	plur	Share Based Compensation Shares Authorized Under Stock Option And Warrants Plans Exercise Price Range Number Of Outstanding Warrants ShareBasedCompensationSharesAuthorizedUnderStockOptionAndWarrantsPlansExercisePriceRangeNumberOfOutstandingWarrants	1277254	shares
CY2024Q2	plur	Share Based Compensation Shares Authorized Under Stock Options And Warrants Plans Exercise Price Range Number Of Exercisable Options And Warrants ShareBasedCompensationSharesAuthorizedUnderStockOptionsAndWarrantsPlansExercisePriceRangeNumberOfExercisableOptionsAndWarrants	1267879	shares
CY2024	plur	Granted Shares GrantedShares	357936	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	2500000	usd
CY2024Q2	us-gaap	Stockholders Equity Other StockholdersEquityOther	35000000	usd
CY2024Q2	plur	Net Income NetIncome	500000	usd
CY2024	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	126000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1709000	usd
CY2024	plur	Bank And Broker Commissions BankAndBrokerCommissions	-92000	usd
CY2023	plur	Bank And Broker Commissions BankAndBrokerCommissions	16000	usd
CY2024	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	1314000	usd
CY2023	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	1084000	usd
CY2024	us-gaap	Gain Loss On Foreign Currency Fair Value Hedge Derivatives GainLossOnForeignCurrencyFairValueHedgeDerivatives	148000	usd
CY2023	us-gaap	Gain Loss On Foreign Currency Fair Value Hedge Derivatives GainLossOnForeignCurrencyFairValueHedgeDerivatives	-157000	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1680000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-798000	usd
CY2024	us-gaap	Interest Expense Debt InterestExpenseDebt	866000	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	843000	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	814000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1641000	usd
CY2017Q4	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.80	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Foreign EffectiveIncomeTaxRateReconciliationTaxCreditsForeign	0.06	pure
CY2024	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	10000000000	ils
CY2024	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	2900000000	usd
CY2024	plur	Income Tax Regular Tax Rate IncomeTaxRegularTaxRate	0.23	pure
CY2024	us-gaap	Management And Service Fees Base Rate ManagementAndServiceFeesBaseRate	0.035	pure
CY2024	plur	Municipality Of Potsdam MunicipalityOfPotsdam	4.55	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2024Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	31414000	usd
CY2024	plur	Accumulated Losses AccumulatedLosses	129286000	usd
CY2024	us-gaap	Profit Loss ProfitLoss	-21344000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-28887000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	69852000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	80534000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3780000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4057000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	25000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	68000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	173000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	237000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	73830000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	84896000	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	73830000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	84896000	usd
CY2024	plur	Effective Tax Rate Los S Carryforward Percentage EffectiveTaxRateLosSCarryforwardPercentage	0	pure
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	plur	Modification Of Warrants To Noncontrolling Interests ModificationOfWarrantsToNoncontrollingInterests		usd
CY2023	plur	Expiration Of Warrants In Ever After ExpirationOfWarrantsInEverAfter		usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Stock Split AdjustmentsToAdditionalPaidInCapitalStockSplit		usd
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		usd
CY2024Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001158780

Files In Submission

Name	View Source	Status
0001213900-24-079861-index-headers.html	Edgar Link	pending
0001213900-24-079861-index.html	Edgar Link	pending
0001213900-24-079861.txt	Edgar Link	pending
0001213900-24-079861-xbrl.zip	Edgar Link	pending
ea0213910-10k_pluriinc.htm	Edgar Link	pending
ea021391001ex10-34_pluriinc.htm	Edgar Link	pending
ea021391001ex21-1_pluriinc.htm	Edgar Link	pending
ea021391001ex23-1_pluriinc.htm	Edgar Link	pending
ea021391001ex31-1_pluriinc.htm	Edgar Link	pending
ea021391001ex31-2_pluriinc.htm	Edgar Link	pending
ea021391001ex32-1_pluriinc.htm	Edgar Link	pending
ea021391001ex32-2_pluriinc.htm	Edgar Link	pending
ea021391001ex4-1_pluriinc.htm	Edgar Link	pending
ea021391001ex97-1_pluriinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
plur-20240630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
ea0213910-10k_pluriinc_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
plur-20240630_def.xml	Edgar Link	unprocessable
plur-20240630_pre.xml	Edgar Link	unprocessable
plur-20240630_cal.xml	Edgar Link	unprocessable
plur-20240630_lab.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLUR
Pluri Inc. Stock $plur

2024 Q3 Form 10-K Financial Statement

#000121390024079861 Filed on September 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR Pluri Inc. Stock $plur

2024 Q3 Form 10-K Financial Statement

#000121390024079861 Filed on September 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLUR
Pluri Inc. Stock $plur